BOY Bodycote Plc

TIDMBOY

RNS Number : 3710A

Bodycote PLC

22 January 2024

www.bodycote.com

22 January 2024

Bodycote plc

Acquisition Update and Announcement of GBP60m Share Buyback Programme

Completion of Lake City HT Acquisition

Further to the announcement on 9 October 2023, the acquisition of Lake City HT successfully completed on 19 January 2024. The consideration paid on closing for Lake City HT was $66.5m (GBP52m) on a cash and debt free basis. After expected tax benefits worth approximately $7.5m, the net economic price paid was $59.0m (GBP46m), resulting in an acquisition multiple of less than 7.5x 2024 EBITDA.

Lake City HT, based in Warsaw, Indiana, is a leading hot isostatic pressing (HIP) and vacuum heat treatment business primarily supplying the orthopaedic implant market as well as Civil Aerospace. It will significantly increase Bodycote's customer reach in the Medical market.

Lake City HT is forecast to have achieved 2023 full year revenues of around $14m (GBP11m), with operating profit expected to be around $6m (GBP5m). The business achieved 30% revenue growth in 2023 and looking ahead is expected to continue to deliver good progress. The acquisition will be accretive to Group profit margins and EPS in 2024 and is expected to exceed Bodycote's cost of capital by 2025.

Bodycote has agreed with Stack Metallurgical Group (SMG) not to complete the acquisition of the business due to a failure to satisfy all closing conditions to the agreement.

Announcement of GBP60m Share Buyback Programme

In light of the lower than anticipated acquisition spend, the Group's strong balance sheet and balanced approach to capital allocation, Bodycote is pleased to announce the intention to launch a share buyback programme of up to GBP60m. The share buyback programme is expected to commence on 18 March 2024. Full details of the programme will be provided on 15 March 2024 at the time of the announcement of Bodycote's full year 2023 results.

Stephen Harris, Group Chief Executive of Bodycote plc, commented:

"Completion of the acquisition of Lake City HT is an exciting further step in our strategy to grow our Specialist Technologies businesses and footprint. This acquisition is an excellent fit, enhances our profitability and earnings per share in addition to allowing us to capitalise on the appealing structural growth opportunities in Medical and Aerospace markets.

The share buyback programme represents an attractive use of our capital. It highlights the strength of the Group's balance sheet, together with our commitment to a balanced and disciplined approach to capital allocation to drive growth and shareholder value."

About Lake City Heat Treating (Lake City HT)

Lake City HT, previously owned by the Davis family, operates out of a single site in Warsaw, Indiana. The site provides HIP and associated heat treatment services. The business predominantly serves the medical orthopaedic implant market but also encompasses aerospace related business.

About Bodycote

With more than 165 accredited facilities in 22 countries, Bodycote is the world's largest provider of thermal processing services. Through Specialist Technologies and classical heat treatment, Bodycote improves the properties of metals and alloys, extending the life of vital components for a wide range of industries, including aerospace, defence, automotive, power generation, medical, oil & gas, construction, and transportation. Customers in all of these industries have entrusted their products to Bodycote's care for more than 50 years. For more information, visit www.bodycote.com .

This announcement contains forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. Bodycote plc accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

For further information, please contact:

Bodycote plc

Stephen Harris, Group Chief Executive

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Susanne Yule

Tel: +44 203 727 1340

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACQPPUQCGUPCGCG

(END) Dow Jones Newswires

January 22, 2024 02:00 ET (07:00 GMT)

Bodycote (LSE:BOY)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025

Bodycote (LSE:BOY)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025